Want to see ARMP full AI Analyst Report?
Ap-Pa02
Pseudomonas Aeruginosa, Lung Infection, Non-Cystic Fibrosis Bronchiectasis
Phase II
Completed
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
Nov 07, 2022
―
Ap-Sa02
Staphylococcus Aureus, Bacteremia, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due To Staphylococcus Aureus
Phase I/II
Completed
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Nov 24, 2021
―
Ap-Pa02
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas, Lung Infection, Lung Infection Pseudomonal
Phase I/II
Completed
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
Oct 15, 2020
―
C16g2
Dental Caries
Phase II
Completed
A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
Jun 21, 2017
―
C16g2 Strip
Dental Caries
Phase II
Completed
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
Feb 10, 2017
―
C16g2 Varnish
Dental Caries
Phase II
Completed
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
Dec 16, 2016
―
Ab-Sa01 (10^8 Pfu Per Phage), Ab-Sa01 (10^9 Pfu Per Phage)
Healthy Volunteers
Phase I
Completed
Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
Apr 27, 2016
―
C16g2 Gel
Dental Caries
Phase II
Completed
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Oct 28, 2015
―
C16g2
Dental Caries
Phase II
Completed
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Jul 01, 2015
―
C16g2
Dental Caries
Phase II
Completed
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
Sep 24, 2014
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Armata Pharmaceuticals Inc (ARMP) have in its pipeline
ARMP is currently developing the following drugs: Ap-Pa02, Ap-Sa02, Ap-Pa02. These drug candidates are in various stages of clinical development as the company works toward FDA approval.